Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Am J Obstet Gynecol. 2017 Aug 16;217(4):418.e1–418.e6. doi: 10.1016/j.ajog.2017.07.020

The Environmental Injustice of Beauty: Framing Chemical Exposures from Beauty Products as a Health Disparities Concern

Ami R Zota 1, Bhavna Shamasunder 2
PMCID: PMC5614862  NIHMSID: NIHMS900879  PMID: 28822238

Abstract

The ObGyn community has issued a call to action to prevent toxic environmental chemical exposures and their threats to healthy human reproduction. Recent committee opinions recognize that vulnerable and underserved women may be disproportionately impacted by environmental chemical exposures and recommend that reproductive health professionals champion policies that secure environmental justice. Beauty product use is an understudied source of environmental chemical exposures. Beauty products can include reproductive and developmental toxicants such as phthalates and heavy metals; however, disclosure requirements are limited and inconsistent. Compared to White women, women of color have higher levels of beauty product-related environmental chemicals in their bodies, independent of socioeconomic status. Even small exposures to toxic chemicals during critical periods of development, such as pregnancy, can trigger adverse health consequences such as impacts on fertility and pregnancy, neurodevelopment, and cancer. In this commentary, we seek to highlight the connections between environmental justice and beauty product-related chemical exposures. We describe racial/ethnic differences in beauty product use such as skin lighteners, hair straighteners, and feminine hygiene products as well as the potential chemical exposures and health risks associated with these products. We also discuss how targeted advertising can take advantage of mainstream beauty norms to influence use of these products. Reproductive health professionals can use this information to advance environmental justice by being prepared to counsel patients who have questions about toxic environmental exposures from beauty care products and other sources. Researchers and health care providers can also promote health-protective policies such as improved ingredient testing and disclosure for the beauty product industry. Future clinical and public health research should consider beauty product use as a factor that may shape health inequities in women’s reproductive health across the life course.

Keywords: toxic environmental chemicals, environmental justice, cosmetics, endocrine-disrupting chemicals, health disparities, reproductive environmental health

Introduction

The American Congress of Obstetrics and Gynecology (ACOG) committee opinion1 emphasizes that toxic environmental chemicals are a threat to human reproduction and there may be differential vulnerability by life stage or social position. More recently, doctors around the world echoed these concerns through the International Federation for Obstetrics and Gynecology (FIGO) committee opinion. FIGO recommended that reproductive health professionals recognize disproportionate burdens to toxic chemical exposures in certain patient populations and champion policies that secure environmental justice.2 Environmental justice integrates concepts of environmental racism and inequality and is defined as the unequal distribution of environmental benefits and pollution burdens based on race.3 An understanding of how both social and environmental factors may jointly influence health is necessary for the elimination of health disparities.4 The Environmental Protection Agency definition, adopted by FIGO, elaborates on this principle for regulatory purposes and defines environmental justice as “the fair treatment and meaningful involvement of all people regardless of race, color, national origin, or income”.2, 5

Beauty product use is an understudied source of environmental chemical exposures and may be one avenue for health professionals to intervene among vulnerable populations such as women of color. Consumer products, and personal care products specifically, are a source of exposure to toxic chemicals for all women.68 Beauty products (one category of personal care products) have limited and inconsistent disclosure of chemical ingredients and most lack adequate data on health and safety.6, 9

Racial/ethnic differences in beauty product use are documented across multiple categories including skin care, hair care, and feminine hygiene (Table 1). However, evidence points to the limits of examining these exposures in isolation. Rather, we argue that health practitioners should consider an “environmental injustice of beauty” approach, which incorporates the social factors that influence beauty product use and the potential for cumulative impacts that may arise due to co-occurring environmental exposures. This approach provides a more comprehensive picture of how environmental factors may shape reproductive health disparities.

Table 1.

Examples of disproportionate beauty product exposures among vulnerable populations

External factors Vulnerable populations Product use Chemical exposures Potential adverse outcomes
Colorism Dark skinned women (globally) Skin lightening creams Mercury Mercury poisoning, neurotoxicity, kidney damage
Hair texture preferences US Black women Hair relaxers and other hair care products Parabens and estrogenic chemicals from placenta Uterine fibroids, premature puberty, and endocrine disruption
Odor discrimination US Black women Vaginal douches and other feminine care products Phthalates and talc powder Gynecological cancers and endocrine disruption

Pre-existing vulnerabilities and cumulative impacts

Beauty products contain multiple chemicals that can adversely impact health, such as formaldehyde, phthalates, parabens, lead, mercury, triclosan, and benzophenone.6, 9, 10 Exposure to one or more of these chemicals has been linked to endocrine disruption, cancer, reproductive harm and impaired neurodevelopment in children.1114 Women ages 18 to 34 are more likely to be “heavy buyers”, purchasing more than ten types of products a year.15 These women and their offspring may experience heightened vulnerability to toxic environmental chemicals if products are used during sensitive periods of development such as preconception or pregnancy.2 Low-income and racial/ethnic minority groups may be further susceptible since they are more frequently exposed to multiple environmental and social risk factors and face poorer health outcomes.16 Nationally representative data of US reproductive-aged women suggest that women of color have higher levels of certain endocrine-disrupting chemicals, such as phthalates and parabens, in their bodies compared to White women, and these racial/ethnic differences are not explained by socioeconomic status.1720 Workers in the beauty industry, who are predominantly women of color and immigrant women, can also face occupational health hazards from chemicals in professional cosmetic products and ad-hoc workplace safety standards.2123 Cumulative assessments of environmental risk factors among socially marginalized groups have historically prioritized place-based pollution sources, such as polluting industries or high traffic density,24, 25 however, beauty product exposures may be elevated in some of the same communities that encounter disproportionate exposures to place-based pollution.26, 27

Social and economic dimensions of product use

The beauty product industry is estimated at $400 billion globally.28 According to market analyses and consumer profiles, multicultural beauty products have outpaced the overall cosmetics market.29 Black consumers purchase nine times more ethnic hair and beauty products than other groups,30, 31 and disproportionately purchase hair relaxers and straighteners. Latinos are the fastest growing ethnic beauty market segment32 and Asian Americans spend 70% more than the national average on skin care products.33

Mass distribution of images that idealize Whiteness can influence sales of hair straighteners, skin lighteners, and odor masking products.34, 35 Racial discrimination based on European beauty norms can lead to internalized racism, body shame, and skin tone dissatisfaction, factors that can influence product use to achieve straighter hair or lighter skin. Thus, beauty product use may be one way that structural discrimination becomes biologically embedded.36, 37

Targeted racial/ethnic marketing can influence product use and related health inequities by taking advantage of mainstream beauty norms.38, 39 In a well-described example of the influences of marketing practices on health disparities, highly targeted menthol cigarette marketing in low-income inner city African-American neighborhoods38, 39 created a racialized geography of tobacco-related health disparities.40

Below, we document evidence of demographic differences in product use and chemical exposures in the beauty industry. We then describe how external factors, such as targeted advertising, can influence product use.

Skin-lightening face creams

Women in Africa, India, the Middle East, Southeast Asia, and the Americas regularly use skin-lightening cosmetics.41, 42 Skin-lightening creams can contain hydroquinone, topical corticosteroids, or inorganic mercury.43 Multiple cases of mercury poisoning, characterized by damage to the kidneys and the central nervous system, have been reported following use of skin-lightening products.44 The US Food and Drug Administration set a maximum allowable level of 1 ppm of mercury in skin products.45 However, skin products with mercury continue to be unregulated and available outside of the US, and these products are still used by certain populations in the US, including Dominican and Mexican American women.4547 In a population-based study of New York City residents, those with the highest urine mercury levels were foreign-born Dominican women of reproductive age, and skin-lightening creams were identified as a source of exposure among highly-exposed populations.45 Similarly, a medical case study reported that a pregnant Mexican American woman’s elevated blood mercury level of 15 μg/L (nearly 3 times the CDC early reporting threshold) was linked to face creams that contained over 20,000 ppm of mercury.46

Skin-lightening creams are sold globally, marketed to darker skinned women. Scholars point to the success of the global skin lightening industry as evidence for the global preference for white/light skin42, 48 and colorism, a social hierarchy based on gradations of skin color that discriminates against darker skin.42 A study of 45 skin bleaching products sold in Harlem, New York found product marketing of skin lighteners traffics in derogatory images that devalue Black skin in order to sell these products.49 Lighter skin tone is an important predictor of higher self-esteem for Black women and is associated with higher educational attainment and earnings among women of color.50, 51

Hair relaxers and straighteners

Compared to White women, African American and African Caribbean women are more likely to use a greater number and variety of hair products52, and to have their hair chemically or professionally treated.31 Use of these products often begins at an early age; in a survey of 201 African American girls, almost half of the parents/guardians reported first application of chemical relaxers to their child’s hair between the ages of 4 and 8.53 Hair products used by Black women are more likely to contain placenta (a potential source of estrogen hormones)54, 55 as well as industrial chemicals such as parabens52 that affect estrogenic pathways.56 Premature reproductive development, such as breast budding, was documented in African American girls exposed to estrogen- or placenta-containing hair products.57 Use of ethnic hair products among African American women has been associated with increased risk of earlier menarche58 and uterine fibroid tumors59. It has also been proposed as a plausible risk factor for excess premenopausal breast cancer risk observed among African American women.60

Hair valuations of “good” (straighter/longer) and “bad” (tightly coiled/kinky) hair can place burdens on Black women to change their hair texture.61, 62 Black women suffer more hair-related anxiety and are twice as likely than White women to experience social pressure at work to straighten their hair.63 For example, the US army historically banned several hairstyles traditionally used by African American women, such as twists and multiple braids, in favor of styles that encouraged straightening or other practices to change hair texture.64

Feminine hygiene and other fragranced products

Black women are more likely than White women to use vaginal douches as well as other fragranced feminine cleansing products such as sprays and wipes.19 In a nationally representative sample of reproductive-aged women, those who reported frequent douching had 150% higher exposures to diethyl phthalate (DEP), a chemical commonly found in fragrances, than douche non-users.19 Differences in DEP exposures between Black and White women were no longer statistically significant after accounting for douching practices, suggesting that vaginal douching may contribute to racial/ethnic disparities in phthalates exposure. Prenatal exposure to DEP can alter maternal sex steroid hormone concentrations during pregnancy65 and may increase the risk of adverse health outcomes in offspring.66, 67 Vaginal douching can also increase risks of bacterial vaginosis68 and pelvic inflammatory disease69, and has been discouraged by ACOG.70

Use of talc powder on the genitals is another practice that is disproportionately practiced by US Black women.71 Talc-based body powder is a possible human carcinogen when used in the genital areas. A pooled analysis of epidemiologic studies found a 24% increased risk of ovarian cancer from genital powder use.72 These risks may be greater among Black women than White women.73, 74

Odor discrimination is a less described but important driver of the feminine cleansing practices described above. According to Ferranti75, imagined odor of African American women was historically used as a basis for moral judgement and an attempt to control sexual behavior. As a result, African American women deodorized and douched in order to be identified with sexual virtue. Advertisers employed targeted marketing towards Black women with messages that encouraged self-consciousness of potential vaginal odors. These habits became embedded as a cultural norm, and now persist outside of marketing efforts.75

Conclusions

ObGyn providers should be aware of the potentially toxic effects of commonly used beauty products, recognize disparities across these demographics, and be prepared to counsel patients who have questions about these and other environmental exposures. While there are few published clinical guidelines, emerging consortiums with published scientific consensus statements can provide support to clinicians.1, 76 Health professional societies can also promote health-protective policies, including improved ingredient testing and disclosure. Lastly, health scientists can collaborate in research to help address existing data gaps. Research on the “exposome”, or the totality of a person’s environmental exposures from conception to death, is a priority for the National Institutes of Environmental Health Sciences.77 Researchers are trying to integrate beauty products into the exposome by characterizing the biologic activity of beauty products using in vitro study designs56 as well as estimating the joint effects of chemicals and psychosocial stress on reproductive endpoints.78 Future research should also consider the heterogeneous social and economic factors that drive product use. Collectively, this multi-pronged approach can help advance the ACOG and FIGO recommendations to secure environmental justice and advance health equity.

Condensation.

Racial/ethnic differences in cosmetic use occur across multiple product categories. Racialized beauty norms may influence product use, toxic chemical exposures, and contribute to health inequalities.

Acknowledgments

The authors thank Dr. Tracey Woodruff (UCSF Program on Reproductive Health and the Environment, funded in part through the National Institute of Environmental Health Sciences and the US Environmental Protection Agency, no conflicts of interest) for her guidance on the manuscript development and Dr. Robin Dodson (Silent Spring Institute; no conflicts of interest) and Ms. Patrice Sutton (UCSF Program on Reproductive Health and the Environment, funded in part through the National Institute of Environmental Health Sciences and the US Environmental Protection Agency, no conflicts of interest) for their comments on an earlier draft of the manuscript. The authors thank anonymous reviewers for their insights as well as Dr. Nate DeNicola (GW School of Medicine & Health Sciences; no conflicts of interest) and Lois Wessel, CFNP (School of Nursing and Health Studies, Georgetown University; no conflicts of interest), funded in part by the Environmental Protection Agency, for helpful comments on our final manuscript.

This work was supported by a grant from the Passport Foundation and the National Institute of Environmental Health Sciences (NIEHS: R00ES019881) and faculty research support from Occidental College. The content is solely the responsibility of the authors and does not necessarily represent the official views of any of the funding agencies.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

The authors report no conflict of interest.

References

  • 1.American Congress of Obstetricians and Gynecologists Committee. Committee opinion no 575: Exposure to toxic environmental agents. Fertil Steril. 2013;100:931–34. doi: 10.1016/j.fertnstert.2013.08.043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Di Renzo GC, Conry JA, Blake J, et al. International Federation of Gynecology and Obstetrics opinion on reproductive health impacts of exposure to toxic environmental chemicals. Int J Gynaecol Obstet. 2015;131:219–25. doi: 10.1016/j.ijgo.2015.09.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Chavis BJ, Lee C. Toxic Wastes and Race in the United States: A National Report on the Racial and Socio-Economic Characteristics of Communities with Hazardous Waste Sites. New York, NY: United Church of Christ Commission on Racial Justice; 1987. [Google Scholar]
  • 4.Brulle RJ, Pellow DN. Environmental justice: human health and environmental inequalities. Annu Rev Public Health. 2006;27:103–24. doi: 10.1146/annurev.publhealth.27.021405.102124. [DOI] [PubMed] [Google Scholar]
  • 5.United States Environmental Protection Agency. Enviromental Justice. http://www.epa.gov/environmentaljustice/. Accessed June 21, 2017.
  • 6.Chow ET, Mahalingaiah S. Cosmetics use and age at menopause: is there a connection? Fertil Steril. 2016;106:978–90. doi: 10.1016/j.fertnstert.2016.08.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Mitro SD, Dodson RE, Singla V, et al. Consumer product chemicals in indoor dust: a quantitative meta-analysis of US studies. Environ Sci Technol. 2016;50:10661. doi: 10.1021/acs.est.6b02023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Woodruff TJ, Zota AR, Schwartz JM. Environmental chemicals in pregnant women in the United States: NHANES 2003–2004. Environ Health Perspect. 2011;119:878. doi: 10.1289/ehp.1002727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Dodson RE, Nishioka M, Standley LJ, Perovich LJ, Brody JG, Rudel RA. Endocrine disruptors and asthma-associated chemicals in consumer products. Environ Health Perspect. 2012;120:935. doi: 10.1289/ehp.1104052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Pierce J, Abelmann A, Spicer L, et al. Characterization of formaldehyde exposure resulting from the use of four professional hair straightening products. J Occup Environ Hyg. 2011;8:686–99. doi: 10.1080/15459624.2011.626259. [DOI] [PubMed] [Google Scholar]
  • 11.Cogliano VJ, Grosse Y, Baan RA, et al. Meeting report: summary of IARC monographs on formaldehyde, 2-butoxyethanol, and 1-tert-butoxy-2-propanol. Environ Health Perspect. 2005;113:1205. doi: 10.1289/ehp.7542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Wang A, Padula A, Sirota M, Woodruff TJ. Environmental influences on reproductive health: the importance of chemical exposures. Fertil Steril. 2016;106:905–29. doi: 10.1016/j.fertnstert.2016.07.1076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Diamanti-Kandarakis E, Bourguignon J-P, Giudice LC, et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev. 2009;30:293–342. doi: 10.1210/er.2009-0002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Gore A, Chappell V, Fenton S, et al. EDC-2: the endocrine society’s second scientific statement on endocrine-disrupting chemicals. Endocr Rev. 2015;36:E1–E150. doi: 10.1210/er.2015-1010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Tabs Analytics. Millennial Women Key to Growth in Cosmetics Industry. 2016 [Google Scholar]
  • 16.Morello-Frosch R, Zuk M, Jerrett M, Shamasunder B, Kyle AD. Understanding the cumulative impacts of inequalities in environmental health: implications for policy. Health Aff. 2011;30:879–87. doi: 10.1377/hlthaff.2011.0153. [DOI] [PubMed] [Google Scholar]
  • 17.James-Todd TM, Chiu Y-H, Zota AR. Racial/ethnic disparities in environmental endocrine disrupting chemicals and women’s reproductive health outcomes: epidemiological examples across the life course. Curr Epidemiol Rep. 2016;3:161–80. doi: 10.1007/s40471-016-0073-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Varshavsky JR, Zota AR, Woodruff TJ. A novel method for calculating potency-weighted cumulative phthalates exposure with implications for identifying racial/ethnic disparities among US reproductive-aged women in NHANES 2001–2012. Environ Sci Technol. 2016;50:10616–24. doi: 10.1021/acs.est.6b00522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Branch F, Woodruff TJ, Mitro SD, Zota AR. Vaginal douching and racial/ethnic disparities in phthalates exposures among reproductive-aged women: National Health and Nutrition Examination Survey 2001–2004. Environ Health. 2015;14:1–8. doi: 10.1186/s12940-015-0043-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Kobrosly RW, Parlett LE, Stahlhut RW, Barrett ES, Swan SH. Socioeconomic factors and phthalate metabolite concentrations among United States women of reproductive age. Environmental Research. 2012;115:11–17. doi: 10.1016/j.envres.2012.03.008. [DOI] [PubMed] [Google Scholar]
  • 21.Adewumi-Gunn TA, Ponce E, Flint N, Robbins W. A preliminary community-based occupational health survey of Black hair salon workers in South Los Angeles. J Immigr Minor Health. 2016:1–7. doi: 10.1007/s10903-016-0521-0. [DOI] [PubMed] [Google Scholar]
  • 22.Quach T, Gunier R, Tran A, et al. Characterizing workplace exposures in Vietnamese women working in California nail salons. Am J Public Health. 2011;101:S271–S76. doi: 10.2105/AJPH.2010.300099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Quach T, Tsoh JY, Le G, et al. Identifying and understanding the role of key stakeholders in promoting worker health and safety in nail salons. J Health Care Poor Underserved. 2015;26:104–15. doi: 10.1353/hpu.2015.0060. [DOI] [PubMed] [Google Scholar]
  • 24.Scammell MK, Montague P, Raffensperger C. Tools for addressing cumulative impacts on human health and the environment. Environ Justice. 2014;7:102–09. [Google Scholar]
  • 25.Solomon GM, Morello-Frosch R, Zeise L, Faust JB. Cumulative environmental impacts: Science and policy to protect communities. Annu Rev Public Health. 2016;37:83–96. doi: 10.1146/annurev-publhealth-032315-021807. [DOI] [PubMed] [Google Scholar]
  • 26.Harley KG, Kogut K, Madrigal DS, et al. Reducing phthalate, paraben, and phenol exposure from personal care products in adolescent girls: findings from the HERMOSA Intervention Study. Environ Health Perspect. 2016;124:1600–07. doi: 10.1289/ehp.1510514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Castorina R, Bradman A, Fenster L, et al. Comparison of current-use pesticide and other toxicant urinary metabolite levels among pregnant women in the CHAMACOS cohort and NHANES. Environ Health Perspect. 2010;118:856. doi: 10.1289/ehp.0901568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Gyan R, Analytics. Global Beauty Care Market 2014–2018 – Research and Markets. 2014 [Google Scholar]
  • 29.Kline. Multicultural Beauty and Grooming Products: US Market Analysis and Opportunities. 2014 [Google Scholar]
  • 30.Nielsen. African-American Consumers are More Relevant Than Ever. 2013 [Google Scholar]
  • 31.Mintel. Black Hair Care. 2013 [Google Scholar]
  • 32.Nielsen. Hispanic Consumers Are the “Foundation” for Beauty Category Sales. 2015 [Google Scholar]
  • 33.Nielsen. Beauty Is More Than Skin Deep for Asian-Americans. 2015 [Google Scholar]
  • 34.Bristor JM, Lee RG, Hunt MR. Race and ideology: African-American images in television advertising. J Public Policy Mark. 1995;14:48–59. [Google Scholar]
  • 35.Parameswaran R, Cardoza K. Melanin on the margins: Advertising and the cultural politics of fair/light/white beauty in India. Journal Commun Monogr. 2009;11:213–74. [Google Scholar]
  • 36.Krieger N. Discrimination and health inequities. Int J Health Serv. 2014;44:643–710. doi: 10.2190/HS.44.4.b. [DOI] [PubMed] [Google Scholar]
  • 37.Bailey ZD, Krieger N, Agénor M, Graves J, Linos N, Bassett MT. Structural racism and health inequities in the USA: evidence and interventions. The Lancet. 2017;389:1453–63. doi: 10.1016/S0140-6736(17)30569-X. [DOI] [PubMed] [Google Scholar]
  • 38.Moore DJ, Williams JD, Qualls WJ. Target marketing of tobacco and alcohol-related products to ethnic minority groups in the United States. Ethn Dis. 1996;6:83–98. [PubMed] [Google Scholar]
  • 39.Smith NC, Cooper-Martin E. Ethics and target marketing: The role of product harm and consumer vulnerability. J Mark. 1997;61:1–20. [Google Scholar]
  • 40.Yerger VB, Przewoznik J, Malone RE. Racialized geography, corporate activity, and health disparities: tobacco industry targeting of inner cities. J Health Care Poor Underserved. 2007;18:10–38. doi: 10.1353/hpu.2007.0120. [DOI] [PubMed] [Google Scholar]
  • 41.Peltzer K, Pengpid S, James C. The globalization of whitening: prevalence of skin lighteners (or bleachers) use and its social correlates among university students in 26 countries. Int J Dermatol. 2016;55:165–72. doi: 10.1111/ijd.12860. [DOI] [PubMed] [Google Scholar]
  • 42.Dixon AR, Telles EE. Skin Color and Colorism: Global Research, Concepts, and Measurement. Annu Rev Sociol. 2017 [Google Scholar]
  • 43.Ladizinski B, Mistry N, Kundu RV. Widespread use of toxic skin lightening compounds: medical and psychosocial aspects. Dermatol Clin. 2011;29:111–23. doi: 10.1016/j.det.2010.08.010. [DOI] [PubMed] [Google Scholar]
  • 44.Chan TY. Inorganic mercury poisoning associated with skin-lightening cosmetic products. Clin Toxicol. 2011;49:886–91. doi: 10.3109/15563650.2011.626425. [DOI] [PubMed] [Google Scholar]
  • 45.McKelvey W, Jeffery N, Clark N, Kass D, Parsons PJ. Population-based inorganic mercury biomonitoring and the identification of skin care products as a source of exposure in New York City. Environ Health Perspect. 2011;119:203–09. doi: 10.1289/ehp.1002396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Dickenson CA, Woodruff TJ, Stotland NE, Dobraca D, Das R. Elevated mercury levels in pregnant woman linked to skin cream from Mexico. Am J Obstet Gynecol. 2013;209:e4–e5. doi: 10.1016/j.ajog.2013.05.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Agrawal S, Sharma P. Current status of mercury level in skin whitening creams. CMRP. 2017 [Google Scholar]
  • 48.Hunter MK. Buying racial capital: Skin-bleaching and cosmetic surgery in a globalized world. The Journal of Pan African Studies. 2011;4:142–64. [Google Scholar]
  • 49.Charles CAD. The Derogatory Representations of the Skin Bleaching Products Sold in Harlem. Rochester, NY: Social Science Research Network; 2011. [Google Scholar]
  • 50.Hunter ML. “If You’re Light You’re Alright” Light Skin Color as Social Capital for Women of Color. Gend Soc. 2002;16:175–93. [Google Scholar]
  • 51.Thompson MS, Keith VM. The Blacker the Berry: Gender, Skin Tone, Self-Esteem, and Self-Efficacy. Gend Soc. 2001;15:336–57. [Google Scholar]
  • 52.James-Todd T, Senie R, Terry MB. Racial/ethnic differences in hormonally-active hair product use: a plausible risk factor for health disparities. J Immigr Minor Health. 2012;14:506–11. doi: 10.1007/s10903-011-9482-5. [DOI] [PubMed] [Google Scholar]
  • 53.Wright DR, Gathers R, Kapke A, Johnson D, Joseph CL. Hair care practices and their association with scalp and hair disorders in African American girls. J Am Acad Dermatol. 2011;64:253–62. doi: 10.1016/j.jaad.2010.05.037. [DOI] [PubMed] [Google Scholar]
  • 54.Li S-TT, Lozano P, Grossman DC, Graham E. Hormone-containing hair product use in prepubertal children. Arch Pediatr Adolesc Med. 2002;156:85–86. doi: 10.1001/archpedi.156.1.85. [DOI] [PubMed] [Google Scholar]
  • 55.Tiwary CM. A survey of use of hormone/placenta-containing hair preparations by parents and/or children attending pediatric clinics. Mil Med. 1997;162:252–56. [PubMed] [Google Scholar]
  • 56.Myers SL, Yang CZ, Bittner GD, Witt KL, Tice RR, Baird DD. Estrogenic and anti-estrogenic activity of off-the-shelf hair and skin care products. J Expos Sci Environ Epidemiol. 2015;25:271–77. doi: 10.1038/jes.2014.32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Tiwary CM. Premature sexual development in children following the use of estrogen-or placenta-containing hair products. Clin Pediatr. 1998;37:733–39. doi: 10.1177/000992289803701204. [DOI] [PubMed] [Google Scholar]
  • 58.James-Todd T, Terry MB, Rich-Edwards J, Deierlein A, Senie R. Childhood hair product use and earlier age at menarche in a racially diverse study population: a pilot study. Ann Epidemiol. 2011;21:461–65. doi: 10.1016/j.annepidem.2011.01.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Wise LA, Palmer JR, Reich D, Cozier YC, Rosenberg L. Hair relaxer use and risk of uterine leiomyomata in African-American women. Am J Epidemiol. 2012;175:432–40. doi: 10.1093/aje/kwr351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Donovan M, Tiwary CM, Axelrod D, et al. Personal care products that contain estrogens or xenoestrogens may increase breast cancer risk. Med Hypotheses. 2007;68:756–66. doi: 10.1016/j.mehy.2006.09.039. [DOI] [PubMed] [Google Scholar]
  • 61.Banks I. Hair matters: Beauty, power, and black women’s consciousness. NYU Press. 2000 [Google Scholar]
  • 62.Robinson CL. Hair as Race: Why “Good Hair” May Be Bad for Black Females. Howard Journal of Communications. 2011;22:358–76. [Google Scholar]
  • 63.Johnson AM, Godsil R, MacFarlane J, Tropp L, Goff PA. The “Good Hair” Study: Explicit and Implicit Attitudes Toward Black Women’s Hair. The Perception Institute; 2017. [Google Scholar]
  • 64.James-Todd T, Fitzgerald T. Caution: ‘Acceptable’ Black Women’s Hairstyles May Harm Health. WBUR: CommonHealth; 2014. http://www.wbur.org/commonhealth/2014/07/14/black-womens-hairstyles-health. [Google Scholar]
  • 65.Sathyanarayana S, Barrett E, Butts S, Wang C, Swan SH. Phthalate exposure and reproductive hormone concentrations in pregnancy. Reproduction. 2014;147:401–09. doi: 10.1530/REP-13-0415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Swan SH, Main KM, Liu F, et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect. 2005:1056–61. doi: 10.1289/ehp.8100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Engel SM, Miodovnik A, Canfield RL, et al. Prenatal phthalate exposure is associated with childhood behavior and executive functioning. Environ Health Perspect. 2010;118:565. doi: 10.1289/ehp.0901470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Holzman C, Leventhal JM, Qiu H, Jones NM, Wang J. Factors linked to bacterial vaginosis in nonpregnant women. Am J Public Health. 2001;91:1664–70. doi: 10.2105/ajph.91.10.1664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Scholes D, Daling JR, Stergachis A, Weiss NS, Wang S-p, Grayston JT. Vaginal douching as a risk factor for acute pelvic inflammatory disease. Obstet Gynecol. 1993;81:601–06. [PubMed] [Google Scholar]
  • 70.ACOG. Committee opinion no 345: Vulvodynia. Obstet Gynecol. 2006;108:1049–52. doi: 10.1097/00006250-200610000-00047. [DOI] [PubMed] [Google Scholar]
  • 71.Wu AH, Pearce CL, Tseng C-C, Pike MC. African Americans and Hispanics remain at lower risk of ovarian cancer than non-Hispanic Whites after considering non-genetic risk factors and oophorectomy rates. Cancer Epidemiol Biomarkers Prev. 2015;24:1094–100. doi: 10.1158/1055-9965.EPI-15-0023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Terry KL, Karageorgi S, Shvetsov YB, et al. Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls. Cancer Prev Res. 2013;6:811–21. doi: 10.1158/1940-6207.CAPR-13-0037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Cramer DW, Vitonis AF, Terry KL, Welch WR, Titus LJ. The association between talc use and ovarian cancer: A retrospective case–control study in two US states. Epidemiology. 2016;27:334. doi: 10.1097/EDE.0000000000000434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Schildkraut JM, Abbott SE, Alberg AJ, et al. Association between body powder use and ovarian cancer: the African American Cancer Epidemiology Study (AACES) Cancer Epidemiol Biomarkers Prev. 2016;10:1411–17. doi: 10.1158/1055-9965.EPI-15-1281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Ferranti M. An odor of racism: Vaginal deodorants in African-American beauty culture and advertising. Advertising & Society Review. 2011;11 [Google Scholar]
  • 76.Bennett D, Bellinger DC, Birnbaum LS, et al. Project TENDR: targeting environmental neuro-developmental risks: the TENDR consensus statement. Environ Health Perspect. 2016;124:A118. doi: 10.1289/EHP358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.National Institute of Environmental Health Sciences. 2012–2017 Strategic Plan: Advancing Science, Improving Health; A Plan for Environmental Health Research. US Department of Health and Human Services; 2012. [Google Scholar]
  • 78.Barrett ES, Parlett LE, Sathyanarayana S, Redmon JB, Nguyen RH, Swan SH. Prenatal stress as a modifier of associations between phthalate exposure and reproductive development: Results from a Multicentre Pregnancy Cohort Study. Paediatr Perinat Epidemiol. 2016;30:105–14. doi: 10.1111/ppe.12264. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES